Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn's Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature

Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn's Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature

Use of ustekinumab in Crohn's disease was approved in 2016, and consequently data regarding its real-world safety are still limited. We here present a 29-year-old woman with severe therapy-refractory Crohn's disease, who developed an anaplastic large cell T cell lymphoma during treatment w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Crohn's and colitis 2019-10, Vol.13 (11), p.1470-1473
Hauptverfasser: Smeets, Fabiënne G M, Liedorp, Paulien R, van der Poel, Marjolein, Miclea, Razvan L, Masclee, Ad A M, Pierik, Marieke
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Crohn Disease - drug therapy
Female
Gastrointestinal Agents - adverse effects
Humans
Lymphoma, Large-Cell, Anaplastic - diagnosis
Positron Emission Tomography Computed Tomography
Short Reports
Ustekinumab - adverse effects
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Use of ustekinumab in Crohn's disease was approved in 2016, and consequently data regarding its real-world safety are still limited. We here present a 29-year-old woman with severe therapy-refractory Crohn's disease, who developed an anaplastic large cell T cell lymphoma during treatment with ustekinumab.
ISSN:1873-9946
1876-4479
DOI:10.1093/ecco-jcc/jjz084